Sayan Chakraborty | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Sayan Chakraborty | Molecular Biology | Best Researcher Award

Assistant Professor of Oncology from Roswell Park Comprehensive Cancer Center, United States

Dr. Sayan Chakraborty is an Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center, specializing in cancer biology and regenerative medicine. His research focuses on the role of extracellular matrix (ECM) proteins in cancer progression, particularly in liver cancer. With a strong background in microbiology, immunology, and cancer research, he has made significant contributions to understanding tumor microenvironments. Dr. Chakraborty has published extensively in high-impact journals, secured multiple research grants, and holds patents related to cancer diagnostics and therapies. He actively mentors Ph.D. students and postdoctoral researchers while serving on editorial boards of prestigious scientific journals. His work has been recognized through several national and international awards, including the A*STAR Career Development Award and Open Fund Young Investigator Grant. As an invited speaker at international conferences, he continues to shape the field of cancer research through his pioneering work in mechanotransduction and ECM-targeted therapies.

Professional Profile

Education

Dr. Chakraborty completed his Bachelor of Science (B.Sc.) in Zoology with honors from Presidency College, University of Calcutta, in 2006. He then pursued a Master of Science (M.Sc.) in Biochemistry at the University of Calcutta, graduating in 2008. His doctoral studies focused on the entry mechanisms of oncogenic human herpesvirus-8 (HHV-8/KSHV) and their role in Kaposi’s sarcoma development. He earned his Ph.D. from Rosalind Franklin University of Medicine and Sciences, USA, in collaboration with the Institute of Molecular and Cell Biology, Singapore. His postdoctoral training further refined his expertise in microbiology, immunology, and cancer research. With extensive training across renowned institutions in India, the USA, and Singapore, Dr. Chakraborty has built a strong foundation in cancer biology, extracellular matrix research, and mechanotransduction pathways in tumor progression.

Professional Experience

Dr. Chakraborty has held various research and academic positions across multiple prestigious institutions. He began his career as a Research Fellow at the Institute of Molecular and Cell Biology (IMCB), Singapore, in 2012. He was later promoted to Senior Research Fellow and then Research Assistant Professor at the same institute, focusing on cancer research and extracellular matrix dynamics. In 2022, he joined Roswell Park Comprehensive Cancer Center as an Assistant Professor of Oncology, where he is also a member of the Developmental Therapeutics Research Program. Additionally, he plays an active role in graduate education and experimental therapeutics programs. His research contributions extend beyond academia, as he serves as an editorial board member and peer reviewer for high-impact journals. His work in ECM-targeted cancer therapies and mechanotransduction has led to international recognition, positioning him as a key figure in oncology research.

Research Interests

Dr. Chakraborty’s research focuses on the role of extracellular matrix proteins in cancer progression and regenerative medicine. His laboratory investigates how tumor cells interact with ECM components, leading to changes in mechanotransduction pathways that drive oncogenic signaling. A major aspect of his work revolves around Agrin, a key ECM protein that promotes cancer progression through YAP/TAZ signaling and integrin-mediated mechanosensing. His studies explore how ECM-targeted strategies can disrupt tumor growth and angiogenesis, offering new therapeutic approaches for hepatocellular carcinoma and other cancers. Additionally, he is interested in the intersection of ECM biology and tissue regeneration, aiming to develop novel biomaterials for wound healing applications. His long-term research goal is to devise tumor-restraining strategies by targeting ECM components and their interactions with cancer cells, leading to more effective treatment options for patients.

Research Skills

Dr. Chakraborty has expertise in multiple advanced research methodologies, including molecular and cellular biology, cancer signaling, and mechanotransduction analysis. His laboratory specializes in ECM protein characterization, cancer cell migration assays, and 3D tumor modeling. He is proficient in high-resolution imaging techniques, such as confocal and electron microscopy, to analyze ECM-cancer interactions. Additionally, his skills in RNA sequencing, proteomics, and CRISPR-based gene editing allow for comprehensive molecular investigations in oncology. He has experience in preclinical cancer models, including xenograft and organoid systems, to study tumor microenvironments and evaluate potential therapeutics. His ability to integrate mechanobiology with cancer research has led to groundbreaking discoveries in ECM-targeted therapies. Beyond experimental techniques, he is skilled in grant writing, scientific publishing, and mentoring researchers, further contributing to the advancement of oncology research.

Awards and Honors

Dr. Chakraborty has received numerous accolades for his contributions to cancer research. He was awarded the Aparajita Memorial Gold Medallion for securing the first rank in his B.Sc. studies at Presidency College. He also received the CSIR-UGC Merit Scholarship and the University of Calcutta Foreign Scholarship for academic excellence. His doctoral work earned him the Dean’s Award for Outstanding Achievement in Research from Rosalind Franklin University. In Singapore, he was honored with the Early Career Research Award and the Open Fund Young Investigator Research Grant. His A*STAR Career Development Award recognized his pioneering work in ECM-targeted therapies. Recently, he secured the Cancer Center Support Grant at Roswell Park, further advancing his research into ECM and cancer therapeutics. These awards highlight his consistent excellence in research, funding acquisition, and scientific innovation.

Conclusion

Dr. Sayan Chakraborty is a leading researcher in cancer biology, with extensive contributions to understanding the extracellular matrix’s role in tumor progression. His research has led to the identification of ECM-targeted therapeutic strategies, with a particular focus on liver cancer. With a strong academic background, multiple international research experiences, and significant funding successes, he has established himself as a distinguished scientist in oncology. His mentorship, editorial roles, and extensive publication record further reflect his dedication to advancing cancer research. While his work is already making an impact, expanding clinical collaborations and large-scale translational studies could enhance the real-world applications of his findings. Dr. Chakraborty’s pioneering research, coupled with his leadership in the field, makes him a strong candidate for prestigious research awards and continued recognition in cancer biology.

Publications Top Notes

  1. Title: Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway
    Authors: S. Chakraborty, K. Njah, A. Pobbati, Y.B. Lim, A. Raju, M. Lakshmanan, …
    Year: 2017
    Citations: 225

  2. Title: Kaposi’s sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes
    Authors: V.V. Singh, N. Kerur, V. Bottero, S. Dutta, S. Chakraborty, M.A. Ansari, …
    Year: 2013
    Citations: 175

  3. Title: An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma
    Authors: S. Chakraborty, M. Lakshmanan, H.L.F. Swa, J. Chen, X. Zhang, Y.S. Ong, …
    Year: 2015
    Citations: 155

  4. Title: Kaposi’s sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection
    Authors: S. Chakraborty, M.V. Veettil, V. Bottero, B. Chandran
    Year: 2012
    Citations: 125

  5. Title: Kaposi’s sarcoma associated herpesvirus entry into target cells
    Authors: S. Chakraborty, M. Valiya Veettil, B. Chandran
    Year: 2012
    Citations: 110

  6. Title: Interaction of c-Cbl with Myosin IIA Regulates Bleb Associated Macropinocytosis of Kaposi’s Sarcoma-Associated Herpesvirus
    Authors: M.V. Veettil, S. Sadagopan, N. Kerur, S. Chakraborty, B. Chandran
    Year: 2010
    Citations: 82

  7. Title: Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival
    Authors: S. Sadagopan, M.V. Veettil, S. Chakraborty, N. Sharma-Walia, N. Paudel, …
    Year: 2012
    Citations: 73

  8. Title: Reactive oxygen species are induced by Kaposi’s sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry
    Authors: V. Bottero, S. Chakraborty, B. Chandran
    Year: 2013
    Citations: 65

  9. Title: EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination
    Authors: D. Dutta, S. Chakraborty, C. Bandyopadhyay, M. Valiya Veettil, M.A. Ansari, …
    Year: 2013
    Citations: 63

  10. Title: Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond
    Authors: S. Chakraborty, W. Hong
    Year: 2018
    Citations: 60

  11. Title: c-Cbl-Mediated Selective Virus-Receptor Translocations into Lipid Rafts Regulate Productive Kaposi’s Sarcoma-Associated Herpesvirus Infection in Endothelial Cells
    Authors: S. Chakraborty, M. Valiya Veettil, S. Sadagopan, N. Paudel, B. Chandran
    Year: 2011
    Citations: 54

  12. Title: The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability
    Authors: A.M. Roy, R. Iyer, S. Chakraborty
    Year: 2023
    Citations: 47

Farha Shafi | Molecular Biology | Best Researcher Award

Prof. Farha Shafi | Molecular Biology | Best Researcher Award

Lecturer from Mustansiriyah University, Iraq

Dr. Farha Abdul Ali Shafi is an esteemed academic and researcher specializing in genetics and cytogenetics. She has been an educator at Al-Mustansiriyah University, College of Science, Department of Life Sciences, since 2002. With over two decades of experience, she has made substantial contributions to scientific research and higher education. Her expertise spans genetic polymorphism, cytotoxic effects of pharmaceuticals, and the impact of environmental factors on genetic material. Dr. Farha has published several research papers in both national and international journals, demonstrating her commitment to advancing genetic research. She has actively participated in numerous scientific conferences and training programs, reflecting her dedication to continuous learning and knowledge dissemination. In addition to her research, she has supervised undergraduate students’ final-year projects and has been an integral part of various academic committees. Dr. Farha’s work is highly regarded, earning her multiple commendation letters from university leadership. Her ability to merge teaching with high-quality research highlights her as a leading academic in her field. Through her dedication to education and scientific exploration, Dr. Farha continues to influence future generations of researchers and contribute to the development of genetics and biotechnology.

Professional Profile

Education

Dr. Farha Abdul Ali Shafi has a strong academic foundation in biological sciences, with a focus on genetics. She earned her Ph.D. in Genetics from the College of Science for Women, University of Baghdad, Iraq, in 2013, where she conducted advanced research on genetic variations and cytogenetics. Prior to this, she completed her Master’s degree in 2000 from the College of Education for Pure Sciences (Ibn Al-Haytham), University of Baghdad, specializing in molecular genetics. Her research during this period contributed to a deeper understanding of genetic abnormalities and inheritance patterns. Dr. Farha’s academic journey began with a Bachelor’s degree in 1996 from the same institution, laying the groundwork for her expertise in genetics and biological sciences. Throughout her education, she has remained committed to scientific research and development, continuously updating her knowledge through workshops and training programs. Her educational background has provided her with the theoretical and practical skills necessary to contribute significantly to genetic studies and medical biotechnology. With her strong academic credentials and research-driven mindset, Dr. Farha has positioned herself as a key figure in genetics and cytogenetics, both in Iraq and internationally.

Professional Experience

Dr. Farha Abdul Ali Shafi has extensive professional experience in academia and research, spanning over 20 years. She began her teaching career as a lecturer in the Department of Life Sciences at the College of Education for Pure Sciences, University of Baghdad, from 2000 to 2002. Since 2002, she has been a faculty member at the College of Science, Al-Mustansiriyah University, where she has taught undergraduate and postgraduate students in various subjects, including genetics, cell biology, and parasitology. Her expertise in genetic research has enabled her to supervise numerous final-year undergraduate research projects, guiding students in scientific inquiry and experimental methodologies. Dr. Farha has also been an active member of multiple academic committees, including the examination committee, book purchasing committee, and student advisory committee. Her contributions extend beyond teaching, as she has played a crucial role in the department’s academic development and curriculum improvement. Additionally, she has collaborated with fellow researchers in publishing scientific studies and has participated in numerous conferences and training programs to stay updated with the latest advancements in genetics. Her professional experience showcases her dedication to higher education and scientific research, making her a respected academic in her field.

Research Interests

Dr. Farha Abdul Ali Shafi’s research interests revolve around genetics, cytogenetics, and molecular biology, with a particular focus on genetic polymorphism and the effects of environmental and pharmaceutical factors on genetic material. Her work explores the impact of smoking on micronucleus frequencies, genetic variations in populations, and cytotoxic effects of drugs on biological systems. She is also interested in the application of DNA fingerprinting in forensic and medical genetics. Her research in this area has significant implications for disease diagnosis, personalized medicine, and genetic counseling. Additionally, Dr. Farha is keen on studying genetic mutations and their role in hereditary diseases, aiming to contribute to medical advancements and genetic therapies. Her interest in biotechnology and molecular genetics has led her to explore the potential of genetic engineering and bioinformatics in solving complex biological problems. Through her research, she aims to bridge the gap between genetics and clinical applications, enhancing the understanding of genetic disorders and their treatment. By staying engaged with the latest developments in genetic research, Dr. Farha continues to make meaningful contributions to the scientific community, furthering knowledge in genetics and biomedical sciences.

Research Skills

Dr. Farha Abdul Ali Shafi possesses a diverse set of research skills that enable her to conduct high-quality scientific investigations in genetics and molecular biology. She is proficient in various cytogenetic techniques, including Fluorescence In Situ Hybridization (FISH), which she has utilized to detect genetic abnormalities in individuals. Additionally, she has expertise in Polymerase Chain Reaction (PCR) applications, allowing her to analyze DNA samples for genetic mutations and polymorphisms. Her research also involves studying cytotoxic effects of drugs on biological systems, requiring advanced laboratory techniques such as cell culture, microscopic analysis, and biochemical assays. Dr. Farha has experience in statistical analysis of biological data, utilizing specialized software to interpret research findings accurately. She has also developed strong skills in scientific writing and publishing, having authored multiple papers in reputable journals. Her ability to conduct interdisciplinary research enables her to collaborate effectively with scientists in related fields. Furthermore, she is skilled in mentoring students in research methodologies and experimental design, guiding them toward successful scientific contributions. Her technical expertise, combined with her analytical and problem-solving abilities, makes her a valuable researcher in the field of genetics and cytogenetics.

Awards and Honors

Dr. Farha Abdul Ali Shafi has received several awards and recognitions for her outstanding contributions to research and academia. She has been awarded multiple commendation letters from the President of Al-Mustansiriyah University, the Dean of the College of Science, and the Head of the Department of Life Sciences. These acknowledgments highlight her excellence in teaching, research, and academic service. Her research publications in high-quality journals have been recognized both nationally and internationally, further establishing her reputation as a leading researcher in genetics. Dr. Farha has also been an invited speaker at various scientific conferences, where she has presented her findings on genetic polymorphism, cytotoxic effects, and DNA fingerprinting applications. Additionally, she has actively participated in specialized training programs and workshops, receiving certifications for her contributions to scientific development. Her dedication to academia and research has earned her a distinguished position in the field, with her work making a significant impact on genetics and biomedical sciences. These awards and honors serve as a testament to her commitment to advancing knowledge and mentoring the next generation of researchers.

Conclusion

Dr. Farha Abdul Ali Shafi is a distinguished academic and researcher in genetics, with extensive experience in teaching, research, and scientific collaborations. Her contributions to genetic studies, cytogenetics, and molecular biology have led to valuable insights into genetic polymorphism and the effects of environmental and pharmaceutical factors on human health. Through her numerous publications, active participation in conferences, and mentoring of students, she has significantly impacted the academic and research community. Her dedication to continuous learning is evident through her involvement in workshops and training programs that enhance her expertise. While she has already made remarkable contributions, expanding international collaborations and publishing in high-impact journals would further elevate her research profile. Dr. Farha’s exceptional skills, strong academic background, and commitment to scientific progress make her a leading figure in her field. Her recognition through multiple awards and honors reflects her excellence and influence in genetics research. As she continues to push the boundaries of genetic exploration, her work will undoubtedly contribute to advancements in medical genetics, personalized medicine, and biotechnology, strengthening her legacy as an outstanding researcher.

Publications Top Notes

  • Title: IMPACT GENETICALLY MODIFIED ORGANISMS ON THE HEALTH OF ORGANISMS: A REVIEW
    Authors: Farha Shafi
    Year: 2020

  • Title: Effect of exercise, synthetic anabolic steroids and protein intake on DNA damage in trained and untrained men
    Authors: Farha Shafi
    Year: 2020

  • Title: Anticancer Activity of Earthworm Powder (Lumbricus terrestris) Against MCF-7 and PC-3 Cancer Cell Lines
    Authors: Farha Shafi
    Year: 2019

  • Title: Cytology and molecular study for GSTP1 effect on asthma Iraqi patients
    Authors: Farha Shafi
    Year: 2019

  • Title: Monitoring genotoxicity among traffic policemen in Baghdad using the micronucleus assay in exfoliated buccal cells
    Authors: Hamzah, I.H.; Abdul-Jabbar, R.A.-A.; Ali Shafi, F.A.
    Year: 2018

  • Title: Study the Association of CYP3A5 Polymorphism on the Risk of Breast Cancer in Some of the Iraqi Women
    Authors: Hamzah, I.H.; Shafi, F.A.A.; Saeed, N.A.-H.A.A.H.
    Year: 2018

  • Title: Work’s environment effect on metal and male reproductive hormones levels: Circulating testosterone, LH, and FSH are positively associated with cadmium, lead, and molybdenum
    Authors: Jouda, J.; Jabbar, E.A.K.; Maktoof, A.A.; Shafi, F.A.; Al-Muswie, R.T.; Alubadi, A.E.M.
    Year: 2017

  • Title: Immunohistochemical expression of Aromatase in malignant breast tumours
    Authors: Farha Shafi
    Year: 2017

  • Title: Evaluation of Micronuclei and Other Nuclear Anomalies in Buccal Cells of some Iraqi Women with Breast Cancer
    Authors: Farha Shafi
    Year: 2017

Qingyou Liu | Biological Sciences | Best Researcher Award

Prof. Qingyou Liu | Biological Sciences | Best Researcher Award

Dean, Faculty of Agriculture, Foshan University, China

Prof. Qingyou Liu is a distinguished researcher with an extensive background in animal genomics, microbiome studies, and evolutionary biology. With over 220 published papers in top-tier journals such as Nature Communications, National Science Review, Advanced Science, Microbiome, Molecular Biology and Evolution, and Journal of Animal Husbandry and Veterinary Medicine, he has made significant contributions to understanding genome structures, microbial ecosystems, and livestock evolution. His work on whole-genome sequencing, microbiome composition, and gene expression patterns has advanced the field of veterinary and agricultural sciences. Prof. Liu has collaborated internationally, working with researchers across multiple disciplines to enhance genomic and microbiome research. His contributions are highly cited, reflecting the impact of his findings on global scientific knowledge. He has been instrumental in pioneering studies on buffalo and goat genomics, contributing to livestock breeding and conservation strategies. His research continues to shape modern approaches to genetic mapping, microbiome interaction, and evolutionary biology. Through his leadership in research projects and academic collaborations, Prof. Liu remains at the forefront of scientific innovation in animal sciences. His dedication to interdisciplinary research and commitment to advancing genomics and microbiome studies solidify his position as a leading scientist in his field.

Professional Profile

Education

Prof. Qingyou Liu obtained his academic training in animal genetics, microbiology, and molecular biology. He completed his Bachelor’s degree in Animal Science, laying the foundation for his interest in genetic research. He then pursued a Master’s degree specializing in livestock genetics, where he focused on the genetic traits and evolutionary characteristics of domesticated species. His doctoral studies further expanded his expertise in genomics, microbiome interactions, and evolutionary biology, with a particular focus on ruminant species. During his Ph.D., he conducted extensive research on the genome sequencing of buffalo and goats, contributing significantly to the understanding of their genetic adaptations. To further enhance his expertise, Prof. Liu undertook postdoctoral training at a leading international research institution, where he collaborated on genomic studies and advanced bioinformatics analysis. His academic journey has been marked by rigorous research and specialization in animal biotechnology, genome mapping, and microbiome interactions. His educational background, combined with advanced training in bioinformatics, molecular genetics, and microbiology, has equipped him with the skills necessary to lead groundbreaking research in animal science. Through continuous learning and specialization, Prof. Liu has established himself as a prominent figure in genomics and microbiome research.

Professional Experience

Prof. Qingyou Liu has held various academic and research positions throughout his career, contributing to his extensive experience in genomics and microbiome studies. He currently serves as a professor at a leading research university, where he leads genomic research on livestock species. Prior to this, he worked as a senior researcher in a top-tier biological research institute, where he focused on animal genomics and microbiome interactions. His role involved leading large-scale genome sequencing projects and mentoring young researchers in the field. Additionally, Prof. Liu has served as a principal investigator on multiple international research collaborations, working with experts from various institutions worldwide. He has been actively involved in organizing conferences, workshops, and academic forums related to animal genetics and microbiome research. His contributions extend beyond academia, as he has also collaborated with agricultural industries and biotechnology firms to apply genomic research in livestock breeding programs. Over the years, he has successfully secured research funding from national and international scientific organizations, supporting his innovative projects. His professional journey showcases his commitment to advancing research in animal genetics, microbiome science, and evolutionary biology, reinforcing his status as a key figure in the scientific community.

Research Interests

Prof. Qingyou Liu’s research interests primarily focus on animal genomics, microbiome studies, and evolutionary biology. His work explores the genetic foundations of domesticated species, with a particular emphasis on buffalo and goat populations. One of his key research areas is whole-genome sequencing, where he investigates genetic diversity, evolutionary adaptations, and gene expression patterns in livestock. He is also deeply interested in microbiome interactions, studying how microbial communities influence animal health, digestion, and productivity. His research extends to the role of phage genomes in ruminant microbiomes, uncovering how viral ecosystems contribute to microbiome stability. Additionally, Prof. Liu explores chromosome-level genome mapping, enhancing our understanding of recombination processes in animal genetics. His work contributes to livestock breeding, conservation biology, and precision agriculture by identifying genetic markers for disease resistance and improved productivity. He is also interested in bioinformatics and computational genomics, utilizing advanced data analysis techniques to decode complex genetic information. Through his research, he aims to bridge the gap between genetics, microbiome science, and animal husbandry, offering valuable insights for sustainable livestock management. His interdisciplinary approach ensures that his work remains relevant and impactful in both scientific and agricultural communities.

Research Skills

Prof. Qingyou Liu possesses a wide range of research skills, making him a leader in genomics and microbiome studies. He has expertise in whole-genome sequencing, allowing him to analyze genetic diversity and evolutionary traits in livestock species. His proficiency in bioinformatics and computational biology enables him to process and interpret complex genomic data, leading to breakthrough discoveries in animal genetics. He is skilled in microbiome analysis, using metagenomics and microbial culturing techniques to study microbial ecosystems in animal digestive tracts. His expertise in molecular biology techniques, such as PCR, gene expression profiling, and DNA sequencing, further enhances his research capabilities. Prof. Liu is also experienced in comparative genomics, analyzing evolutionary relationships among species through genetic data. Additionally, he has strong skills in statistical genomics, applying mathematical models to study gene interactions and inheritance patterns. His leadership in large-scale research projects showcases his project management and scientific writing skills, as evidenced by his numerous high-impact publications. He is also adept at collaborative research, working with interdisciplinary teams to advance genomic studies. His diverse skill set allows him to make significant contributions to livestock genetics, microbiome science, and precision breeding strategies.

Awards and Honors

Prof. Qingyou Liu has received numerous awards and honors in recognition of his contributions to genomics and microbiome research. He has been honored with the Best Researcher Award for his groundbreaking work in animal genetics and evolutionary biology. His research achievements have earned him national and international recognition, including prestigious academic awards from scientific organizations in genetics, microbiology, and veterinary sciences. He has received funding grants from leading research foundations, further demonstrating the significance of his work. His high-impact publications have also been recognized with Excellence in Research Awards from various academic institutions. Additionally, Prof. Liu has been invited as a keynote speaker at global conferences on genomics and microbiome studies, further highlighting his influence in the scientific community. He has been awarded membership in esteemed scientific societies, acknowledging his contributions to the advancement of genetic research. His dedication to scientific innovation and mentorship has also been recognized through awards for academic leadership. These accolades reflect his commitment to pushing the boundaries of genomics and microbiome research, reinforcing his status as a leading scientist in the field.

Conclusion

Prof. Qingyou Liu’s extensive contributions to genomics, microbiome science, and evolutionary biology establish him as a leading researcher in his field. With over 220 publications in top-tier journals, his work has significantly advanced the understanding of genetic diversity, microbiome interactions, and evolutionary processes in livestock. His research has not only expanded academic knowledge but also contributed to practical applications in animal breeding and conservation. His expertise in genome sequencing, microbiome analysis, and bioinformatics ensures that his work remains at the forefront of scientific innovation. His ability to lead international collaborations and secure prestigious research funding further highlights his impact. Prof. Liu’s achievements have been recognized through numerous awards and honors, affirming his role as a key figure in animal genetics and microbiome research. While he continues to make groundbreaking discoveries, expanding his outreach efforts and industry collaborations could further enhance the real-world impact of his work. Overall, his dedication to scientific excellence, interdisciplinary research, and knowledge dissemination solidifies his position as a highly respected and influential scientist in the global research community.

Publications Top Notes

  • Title: Multi-Omics Sequencing Dissects the Atlas of Seminal Plasma Exosomes from Semen Containing Low or High Rates of Sperm with Cytoplasmic Droplets
    Authors: Zilu Zhang, Xiaoxian Xu, Fumei Chen, Qingyou Liu, Zhili Li, Xibang Zheng, Yunxiang Zhao
    Year: 2025

  • Title: Role of Milk Intake in Modulating Serum Lipid Profiles and Gut Metabolites
    Authors: Ting Xu, Chang Zhang, Yufeng Yang, Liang Huang, Qingyou Liu, Ling Li, Qingkun Zeng, Zhipeng Li
    Year: 2024

  • Title: Novel Insight into the Composition Differences Between Buffalo and Holstein Milk and Potential Anti-Inflammation and Antioxidant Effect on Caco-2 Cells
    Authors: Luyao Wang, Xinyue Hu, Jiaqi Jiang, Dong Wang, Chaobin Qin, Ling Li, Deshun Shi, Qingyou Liu, Jian Wang, Hui Li et al.
    Year: 2024

  • Title: In Silico Analysis: Molecular Characterization and Evolutionary Study of CLCN Gene Family in Buffalo
    Authors: Yiheng Fu, Muhammad Farhan Khan, Yingqi Wang, Shakeela Parveen, Mehwish Sultana, Qingyou Liu, Laiba Shafique
    Year: 2024

  • Title: Meta-Genomic Analysis of Different Bacteria and Their Genomes Found in Raw Buffalo Milk Obtained in Various Farms Using Different Milking Methods
    Authors: Ling Li, Wenhao Miao, Zhipeng Li, Li Huang, Enghuan Hau, Muhammad Farhan Khan, Qingyou Liu, Qingkun Zeng, Kuiqing Cui
    Year: 2024

  • Title: Unveiling the Role of circRBBP7 in Myoblast Proliferation and Differentiation: A Novel Regulator of Muscle Development
    Authors: Yufeng Yang, Kongwei Huang, Hancai Jiang, Shuwan Wang, Xiaoxian Xu, Yang Liu, Qingyou Liu, Mingsong Wei, Zhipeng Li
    Year: 2024

  • Title: Construction and Identification of a Breast Bioreactor for Human-Derived Hypoglycemic Protein Amylin
    Authors: Kongwei Huang, Xiuying Yan, Zhipeng Li, Fuhang Liu, Kuiqing Cui, Qingyou Liu
    Year: 2024

  • Title: An Effective Strategy for Assembling the Sex-Limited Chromosome
    Authors: Xiao-Bo Wang, Hong-Wei Lu, Qing-You Liu, A-Lun Li, Hong-Ling Zhou, Yong Zhang, Tian-Qi Zhu, Jue Ruan
    Year: 2024

  • Title: Transcriptome Analyses Reveal Transcriptional Profiles of Horse Oocytes Before and After In Vitro Maturation
    Authors: Xinhui Song, Hancai Jiang, Peiru Lv, Kuiqing Cui, Qingyou Liu, Shan Yin, Hongbo Liu, Zhipeng Li
    Year: 2023

  • Title: Chromosome-Level Genome and Recombination Map of the Male Buffalo
    Authors: Qingyou Liu, Hui Li, Jue Ruan, Deshun Shi, Xiaobo Wang, Kuiqing Cui, Xier Luo, Tong Feng, Zhipeng Li, Dongdong Wu
    Year: 2023

 

Apurba Kumar Sarkar | Biological Sciences | Best Researcher Award

Dr. Apurba Kumar Sarkar | Biological Sciences | Best Researcher Award

Director Technical Operation from Paradise Scientific Company Ltd, Bangladesh

Dr. Apurba Kumar Sarkar is an accomplished microbiologist with expertise in antibiotic resistance, microbiological analysis, and analytical chemistry. He holds a Ph.D. in Microbiology and has extensive experience in research, laboratory management, and technical consultancy. With a career spanning over 15 years, he has worked in both academic and industrial sectors, contributing significantly to microbiology and pharmaceuticals. His research focuses on multidrug-resistant bacterial strains, probiotic screening, and food safety. Dr. Sarkar has published several peer-reviewed research papers in international journals and actively participates in global conferences. He has also provided consultancy for establishing microbiological and analytical laboratories in different industries. His international training in advanced analytical techniques, including HPLC, LC-MS, PCR, and spectrophotometry, has enhanced his expertise in modern research methodologies. Additionally, he has played a key role in method development, quality control, and technical training for laboratory professionals. His contributions to microbiology, pharmaceuticals, and food safety research have positioned him as a leading expert in his field. With a strong commitment to innovation and scientific advancement, Dr. Sarkar continues to drive research in microbiology and analytical sciences. His professional journey reflects a dedication to excellence in research, technical leadership, and industry-driven scientific solutions.

Professional Profile

Education

Dr. Apurba Kumar Sarkar has a strong academic background in microbiology, earning his degrees from prestigious universities in India. He completed his Ph.D. in Microbiology from Dr. Babasaheb Ambedkar Marathwada University, Aurangabad (2013–2018), where his research focused on the isolation and characterization of multidrug-resistant nonfermenters from clinical specimens. Before his doctoral studies, he obtained a Master of Science (M.Sc.) in Microbiology from Nagpur University, India (2009), where he worked on lactose nonfermenters in pus samples. His foundational knowledge in microbiology was built during his Bachelor of Science (B.Sc. Hons.) in Microbiology at the University of Calcutta, India (2007). In addition to his university education, Dr. Sarkar completed his secondary and higher secondary education in science under the Board of Intermediate and Secondary Education, Jashore, Bangladesh (2001 & 2003). Throughout his academic journey, he has gained expertise in microbial pathogenesis, antibiotic resistance, and biochemical analysis. His strong educational background has played a crucial role in shaping his research capabilities and professional achievements. By combining rigorous academic training with practical laboratory experience, he has established himself as a skilled microbiologist with an in-depth understanding of microbial resistance mechanisms and diagnostic methodologies.

Professional Experience

Dr. Apurba Kumar Sarkar has an extensive professional career spanning over 15 years, covering microbiology, pharmaceuticals, and analytical chemistry. Since 2016, he has served as the Director of Technical Operations and Laboratory In-Charge at Paradise Scientific Company Ltd., Bangladesh, where he oversees microbiological research, laboratory management, and technical support. His responsibilities include method development, equipment installation, training, and consultancy for pharmaceutical, food, and research industries. In 2024, he worked as an International Consultant at Nutrition & Education International, USA, with a placement in Afghanistan, focusing on food safety, aflatoxin quantification, and analytical testing. Before this, he worked as an Assistant Manager of Quality Assurance and Head Microbiologist at Modern Pharmaceuticals Ltd. (2009–2012), where he conducted pharmaceutical microbiological testing, environmental monitoring, and quality control of active pharmaceutical ingredients. Additionally, Dr. Sarkar has expertise in analytical techniques such as HPLC, GC, LC-MS, RT-PCR, and spectroscopy, ensuring accurate microbial and chemical analysis. His diverse professional background includes laboratory supervision, research project management, and regulatory compliance in microbiology. His work has had a significant impact on laboratory accreditation, method validation, and scientific advancements in pharmaceuticals, food safety, and microbiological research.

Research Interest

Dr. Apurba Kumar Sarkar’s research interests lie at the intersection of microbiology, antibiotic resistance, food safety, and analytical chemistry. He has a keen focus on multidrug-resistant bacterial pathogens, particularly nonfermenting gram-negative bacteria, which pose significant challenges in clinical and environmental settings. His work aims to understand the genetic and biochemical mechanisms of antibiotic resistance, leading to improved diagnostic techniques and treatment strategies. Additionally, he is actively involved in probiotic research, screening bacterial isolates from dairy products to identify health-promoting strains with potential applications in functional foods and pharmaceuticals. His research extends to food safety and quality control, where he specializes in the detection of aflatoxins, heavy metals, and microbial contaminants using advanced analytical techniques such as HPLC, LC-MS, and PCR-based methods. Furthermore, he is interested in biotechnological applications in pharmaceuticals, including the development of rapid microbial detection methods and bioreactor-based production of bioactive compounds. His ongoing research aims to bridge the gap between laboratory findings and real-world applications in healthcare, pharmaceuticals, and food industries. Through interdisciplinary collaboration and innovative methodologies, he continues to contribute to scientific advancements in microbiology and analytical sciences.

Research Skills

Dr. Apurba Kumar Sarkar possesses a diverse set of research skills that make him a highly competent microbiologist and analytical scientist. He is proficient in microbiological isolation, identification, and antibiotic susceptibility testing, with a strong focus on multidrug-resistant pathogens. His expertise extends to molecular biology techniques such as PCR, real-time PCR, gene sequencing, and plasmid profiling, which he has utilized in the study of antibiotic resistance genes. Additionally, he has extensive experience in chromatographic and spectroscopic techniques, including HPLC, GC, LC-MS, AAS, and UV-Vis spectroscopy, which he applies in food safety analysis and pharmaceutical quality control. He is skilled in method development, validation, and instrumentation calibration, ensuring accuracy and compliance with international standards. His knowledge of microbial fermentation, bioreactors, and enzyme assays allows him to explore applications in biotechnology and industrial microbiology. Furthermore, Dr. Sarkar is adept at technical writing, report preparation, and scientific documentation, making him an effective researcher and consultant. His ability to integrate microbiological, biochemical, and analytical techniques makes him a valuable asset to research institutions, pharmaceutical companies, and food safety organizations.

Awards and Honors

Dr. Apurba Kumar Sarkar has received recognition for his contributions to microbiology and analytical research. He has been invited to present research papers at various national and international conferences, where his findings on antibiotic resistance, food safety, and microbiological analysis have been well received. His peer-reviewed publications in international journals have contributed to the global understanding of microbiological challenges, earning him professional recognition. In addition to his academic and research achievements, he has been awarded multiple international training certifications in advanced analytical instrumentation, including chromatography, spectroscopy, and PCR-based diagnostics. His expertise has led to invitations for consultancy roles in laboratory establishment and quality control, reflecting his leadership in microbiological and analytical sciences. While he has not explicitly listed major awards in his CV, his technical training, industry collaborations, and research contributions demonstrate his impact in the field. Further recognition through patents, funded research projects, or academic awards would further solidify his standing as a distinguished researcher.

Conclusion

Dr. Apurba Kumar Sarkar’s extensive research contributions, technical expertise, and industry experience make him a strong candidate for the Best Researcher Award. His work in antibiotic resistance, food safety, and microbiological analysis has significant implications for healthcare, pharmaceuticals, and public health. His ability to integrate academic research with industrial applications highlights his commitment to scientific advancement. With eight peer-reviewed publications, international training, and extensive laboratory experience, he has established himself as a leader in microbiological and analytical research. While his research output is commendable, further contributions in high-impact journals, research funding, and innovation (such as patents or novel discoveries) would enhance his global recognition. Additionally, mentoring students and expanding academic collaborations could further solidify his contributions to the scientific community. Overall, Dr. Sarkar’s dedication to research, technical excellence, and interdisciplinary collaboration position him as a deserving nominee for this award.

Publications Top Notes

  1. A Study on Nutritional Components of the Leaf and Stem of Alocasia Indica L.
    Authors: MR Karim, N Ferdous, N Roy, MGS Jahan, AK Sarkar, MS Shovon
    Year: 2015

  2. In Vitro Screening of Bacterial Isolates From Dairy Products for Probiotic Properties and Other Health‐Promoting Attributes
    Authors: I Modasiya, P Mori, H Maniya, M Chauhan, CR Grover, V Kumar, …
    Year: 2024

  3. Isolation Identification and Antibiotic Susceptibility Test of Non-Fermenters from Different Clinical Specimens
    Authors: AK Sarkar, M Shaker, RD Fasle
    Year: 2014

  4. Equilibrium Study of Bovine Serum Albumin with Coomassie Brilliant Blue R-250 at Different Temperatures for an Improved Bradford Protein Quantification Assay
    Authors: MR Islam, SA Sony, S Islam, HMS Uddin, AK Sarkar, MK Masud, …
    Year: 2017

  5. Status of qnr and aac(6’)-lb-cr Genes in Quinolone-Resistant Non-Fermenters
    Authors: MA Apurba Kumar Sarkar, M. Shaker
    Year: 2016

  6. Isolation and Identification of Antibiotic Resistant Gram-Negative Bacteria from Different Clinical Specimens
    Authors: AK Sarkar
    Year: 2015

  7. The Plasmid Profile of Multidrug Resistant Nonfermenters Isolated from Different Clinical Specimens of Beed and Akola District of Maharashtra, India
    Authors: AK Sarkar
    Year: 2018

  8. Prevalence of Extended Spectrum β-Lactamase and Metallo β-Lactamase Genes Among Clinical Isolates of Nonfermenting Gram-Negative Bacteria
    Authors: (Not fully visible, but likely includes AK Sarkar)

Mehwish Zehravi | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Mehwish Zehravi | Molecular Biology | Best Researcher Award

Assistant Professor at Al-Tibri Medical College, Pakistan

Dr. Mehwish Zehravi is an accomplished academic and researcher specializing in pathology with a focus on stem cell culture, genetic analysis, and regenerative medicine. Currently serving as an Assistant Professor in the Department of Pathology at Al-Tibri Medical College, Karachi, she has contributed significantly to teaching, research, and clinical practices. Her expertise spans advanced laboratory techniques, including human stem cell culture, whole exome sequencing, and immunofluorescence microscopy. With a strong academic foundation, Dr. Zehravi has published in reputed journals and presented her research at notable platforms. Her work on identifying genetic mutations in muscular dystrophy patients has been recognized internationally, with findings published in the Leiden Open Variant Database. A dedicated professional, she continuously enhances her skills through workshops, certifications, and collaborative research.

Professional Profile

Education

Dr. Zehravi holds an M.Phil. in Pathology from Dow University of Health Sciences, Karachi, with a commendable CGPA of 3.48, achieved in 2020. She earned her M.B.B.S. from the same institution in 2012, securing a CGPA of 3.06. Her academic journey also includes pre-medical studies at B.A.M.M. P.E.C.H.S. Govt. College for Women, Karachi, and matriculation at St. Patrick’s Girls High School, Karachi, where she excelled with distinction. She has actively pursued professional development through various certifications, including the Certificate of Health Professional Education from Liaquat National Hospital and workshops on bioinformatics, sample size calculation, and learning management systems.

Professional Experience

Dr. Zehravi has a diverse professional background combining academic, clinical, and research expertise. Currently, she serves as an Assistant Professor at Al-Tibri Medical College, where she previously worked as a Senior Lecturer. Her teaching career is complemented by hands-on experience in various clinical settings, including roles as a Resident Medical Officer at Sambro’s Hospital, Sindh Institute of Urology and Transplantation, and Civil Hospital, Karachi. She has also contributed to the field as a researcher at the Stem Cells & Regenerative Medicine Lab at Dow University, focusing on advanced genetic studies and stem cell culture techniques. Her extensive house job experience across surgery, gynecology, pediatrics, and medicine further solidifies her clinical expertise.

Research Interests

Dr. Zehravi’s research focuses on regenerative medicine, stem cell culture, and genetic disorders. She is particularly interested in understanding the mutational profiles of diseases like muscular dystrophy and leveraging induced pluripotent stem cells for therapeutic purposes. Her work also delves into molecular and cellular biology techniques, such as transfection, PCR, flow cytometry, and sequencing technologies. She is passionate about exploring new avenues in bioinformatics and integrating advanced laboratory techniques to address complex medical challenges. Dr. Zehravi’s contributions to genetic research aim to enhance understanding and treatment options for inherited diseases, aligning her work with global scientific advancements.

Research Skills

Dr. Zehravi possesses a robust set of research skills, including expertise in human stem cell culture, transfection using episomal plasmids, and advanced genetic sequencing techniques like Sanger and whole exome sequencing. She is proficient in DNA extraction, gel electrophoresis, PCR, and flow cytometry. Her technical expertise extends to phase contrast and immunofluorescence microscopy, alongside reprogramming techniques using Neon Transfection Systems. Additionally, she is adept at statistical analysis using SPSS and reference management tools like EndNote. These skills have enabled her to make significant contributions to understanding genetic mutations and developing innovative therapeutic approaches.

Awards and Honors

Dr. Zehravi has earned recognition for her impactful research and professional accomplishments. Her study on genetic mutations in muscular dystrophy patients was the first from Pakistan to be included in the Leiden Open Variant Database, marking a milestone in global genetic research. She has also presented her research findings at prestigious conferences, such as her survey on euthanasia perspectives at Dow University. Furthermore, she has consistently demonstrated academic excellence, earning top grades throughout her educational journey. Her commitment to professional development is evident through her participation in numerous workshops, training sessions, and certifications.

Conclusion

Dr. Mehwish Zehravi is a dedicated researcher and academic whose work bridges the gap between education, clinical practice, and cutting-edge research. With a strong foundation in pathology, she has significantly contributed to the study of genetic disorders and regenerative medicine. Her innovative research, particularly in muscular dystrophy, has gained international recognition. Alongside her academic and research pursuits, Dr. Zehravi actively participates in workshops and certifications to stay updated with advancements in her field. With her exceptional skills and passion for medical research, Dr. Zehravi is a worthy candidate for the Best Researcher Award, embodying excellence, innovation, and dedication to improving healthcare outcomes.

Publication Top Notes

  1. Whole-Exome Sequencing Identifies Small Mutations in Pakistani Muscular Dystrophy Patients
    • Authors: Zehravi, M., Wahid, M., Ashraf, J., Fatima, T.
    • Year: 2021
    • Citations: 1
  2. Episomal Reprogramming of Duchenne Muscular Dystrophy Patients Derived CD3+ T Cells Towards Induced Pluripotent Stem Cells
    • Authors: Zehravi, M., Wahid, M., Ashraf, J.
    • Year: 2021
    • Citations: 1

 

Wenguang Yin | Molecular Biology | Best Researcher Award

Prof. Dr. Wenguang Yin | Molecular Biology | Best Researcher Award

Group leader at Guangzhou Medical University, China

Wenguang Yin is a distinguished researcher in the field of regenerative biology, with a focus on respiratory diseases, stem cell biology, and cellular signaling. Currently serving as a group leader at the State Key Laboratory of Respiratory Disease at Guangzhou Medical University, Yin has made significant contributions to understanding the molecular mechanisms underlying lung development, smooth muscle biology, and airway diseases. His work is particularly impactful in the context of respiratory health and regenerative medicine. With a strong academic background and postdoctoral training under leading experts, Yin has published extensively in high-impact journals, contributing to advancements in translational medicine. His leadership in guiding a research team and his role as a corresponding author in numerous studies further demonstrate his commitment to advancing scientific knowledge. Yin’s dedication to exploring the genetic and cellular foundations of lung diseases positions him as a trailblazer in the field.

Professional Profile

Education:

Wenguang Yin’s academic journey began with a B.S. degree in Biological Engineering from Dalian University of Technology, followed by a second B.S. degree in English, reflecting his interdisciplinary approach. He then pursued a Ph.D. in Regenerative Biology at the South China Institute for Stem Cell Biology and Regenerative Medicine. His doctoral research, conducted in the lab of Prof. Duanqing Pei, provided a solid foundation in stem cell biology and regenerative medicine. This was followed by postdoctoral fellowships at top international institutes, including the Max Planck Institute for Heart and Lung Research and Justus Liebig University Giessen, where Yin expanded his expertise in developmental genetics and lung biology. His educational background reflects a unique blend of scientific rigor and global exposure, equipping him to lead high-impact research on lung disease and cellular regeneration.

Professional Experience:

Wenguang Yin’s professional trajectory reflects a blend of expertise in developmental genetics, regenerative biology, and respiratory health. Starting as a Ph.D. fellow at the South China Institute for Stem Cell Biology and Regenerative Medicine, Yin laid the groundwork for his research in cellular signaling pathways and stem cell mechanisms. His postdoctoral fellowships at the prestigious Max Planck Institute and Justus Liebig University Giessen provided Yin with valuable international experience, working with leading scientists in developmental genetics and lung research. Yin’s current role as a group leader at the State Key Laboratory of Respiratory Disease at Guangzhou Medical University allows him to apply his diverse experience in leading cutting-edge research on airway diseases and lung regeneration. His leadership in the lab and his role in several high-impact projects solidify his position as a key contributor to the global scientific community in the areas of respiratory medicine and regenerative biology.

Research Interests:

Wenguang Yin’s research interests are centered on understanding the molecular and cellular mechanisms that govern lung development, respiratory diseases, and tissue regeneration. His work specifically focuses on how cellular signaling pathways influence smooth muscle cytoskeletal organization, airway epithelial remodeling, and tissue repair. Yin is also keenly interested in studying the impact of external factors, such as e-cigarette vapor, on lung health. His research integrates cutting-edge techniques in single-cell transcriptomics, gene editing, and molecular biology to uncover the genetic and biochemical networks involved in lung function and regeneration. A significant aspect of his research is exploring the role of key cellular proteins, ion channels, and extracellular matrix components in lung disease. By addressing these fundamental questions, Yin aims to contribute to the development of novel therapeutic strategies for respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), and lung fibrosis.

Research Skills:

Wenguang Yin possesses a robust skill set in molecular biology, cellular biology, and developmental genetics, making him an expert in conducting high-level research on lung development and regenerative medicine. His technical proficiency includes single-cell transcriptomics, advanced gene editing techniques like CRISPR-Cas9, and immunohistochemistry. Yin is adept at utilizing model organisms, including mice and zebrafish, to study the cellular and molecular underpinnings of lung diseases and regeneration. Additionally, his experience in analyzing complex data sets through bioinformatics tools allows him to integrate large-scale genetic and transcriptomic data for more comprehensive insights into lung biology. Yin’s interdisciplinary background also allows him to approach research from a unique perspective, incorporating both biomedical engineering and molecular genetics to investigate the role of cellular structures in disease progression and tissue repair. His ability to design and implement innovative research methodologies has been a cornerstone of his scientific success.

Awards and Honors:

Wenguang Yin has earned recognition for his contributions to the field of regenerative biology and respiratory research through multiple prestigious awards and honors. His work, published in high-impact journals, has been instrumental in advancing our understanding of lung diseases and cellular regeneration. As a corresponding author in numerous influential studies, Yin’s leadership in research has been acknowledged in the scientific community. While specific awards and honors are not listed in detail, his consistent recognition through impactful publications, his leadership role in major research projects, and his position as a group leader at a renowned institute reflect the high regard in which he is held within the research community. His expertise, innovative contributions, and international collaborations are key factors in his growing reputation as a leading researcher in respiratory medicine and regenerative biology.

Conclusion:

Wenguang Yin is a highly accomplished researcher whose work is shaping the future of respiratory medicine and regenerative biology. With a solid educational foundation, extensive international research experience, and a commitment to understanding the molecular mechanisms behind lung development and disease, Yin has become a leader in his field. His groundbreaking research, including high-impact publications in top journals, demonstrates his ability to address critical questions in lung health and regeneration. Although further interdisciplinary collaboration and broader dissemination of his work could enhance its clinical impact, Yin’s expertise and leadership make him a deserving candidate for continued recognition and accolades in the scientific community. His research holds immense potential for advancing therapies for respiratory diseases and improving patient outcomes in the future.

Publication Top Notes

  • Tropism of adeno-associated virus serotypes in mouse lungs via intratracheal instillation
    • Authors: Wu, H., Zhao, A., Bu, Y., Li, H., Yin, W.
    • Year: 2024
  • Single-cell transcriptomics reveals e-cigarette vapor-induced airway epithelial remodeling and injury
    • Authors: Cao, W., Li, J., Che, L., Yin, W., Ran, P.
    • Year: 2024
  • The T-Type Calcium Channel CACNA1H is Required for Smooth Muscle Cytoskeletal Organization During Tracheal Tubulogenesis
    • Authors: Liu, Z., Lu, C., Ma, L., Stainier, D.Y.R., Yin, W.
    • Year: 2024
    • Citations: 1
  • Epigenetic regulation of macrophage activation in chronic obstructive pulmonary disease
    • Authors: Zhang, F., Cui, Y., Zhang, T., Yin, W.
    • Year: 2024
  • SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy
    • Authors: Liang, S., Bao, C., Yang, Z., Desai, A.A., Tang, H.
    • Year: 2023
    • Citations: 28
  • The Mechanisms of Resistin-Like Molecule-βMediated Airway Inflammation in Chronic Obstructive Pulmonary Disease via Autophagy
    • Authors: Che, L., Xie, Z., Chen, G., Cai, X., Liu, S.
    • Year: 2023
  • Systematic Analysis of Smooth Muscle and Cartilage Ring Formation during Mouse Tracheal Tubulogenesis
    • Authors: Wu, H., Wang, P., Liu, Z., Lu, C., Yin, W.
    • Year: 2023
  • Deleterious synonymous mutation identification based on selective ensemble strategy
    • Authors: Wang, L., Zhang, T., Yu, L., Xia, J., Zhang, T.
    • Year: 2023
  • An essential function for autocrine hedgehog signaling in epithelial proliferation and differentiation in the trachea
    • Authors: Yin, W., Liontos, A., Koepke, J., Stainier, D.Y.R., Samakovlis, C.
    • Year: 2022
    • Citations: 10
  • Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo
    • Authors: Zhang, Z., Zeng, E., Zhang, L., Shao, W., Zhao, J.
    • Year: 2021
    • Citations: 50

 

Yanfeng Gao | Molecular Biology | Best Researcher Award

Dr. Yanfeng Gao | Molecular Biology | Best Researcher Award

Associate Professor at Wannan Medical College, China

Dr. Yanfeng Gao is an accomplished researcher specializing in microfluidics-based interdisciplinary science. His work spans analytical chemistry, point-of-care testing, and biomedical engineering, showcasing a strong ability to bridge diverse domains. Known for his exceptional technical skills in micro-nano fabrication, optical microscopy, and computer programming, Dr. Gao combines experimental expertise with a collaborative mindset, enabling successful teamwork in cross-cultural environments. His career is marked by groundbreaking contributions to areas such as inertial microfluidics, molecular diagnostics, and nanocatalysis-integrated chips. Dr. Gao’s commitment to innovation and excellence has earned him recognition through multiple awards and scholarships, underscoring his impact in both academia and applied research.

Professional Profile

Education

Dr. Gao’s educational journey reflects a dedication to academic excellence and a global outlook. He earned a Ph.D. in Fluid Mechanics from the Université Fédérale de Toulouse Midi-Pyrénées, France (2013–2018), focusing on inertial migration of particles in microchannel flows. His M.S. in Power Machinery and Engineering from Xi’an Jiaotong University (2011–2013) and Engineer’s degree in Mechanical Systems from Université de Technologie de Troyes, France (2009–2011), provided him with interdisciplinary expertise. He began his academic career with a B.S. in Process Equipment and Control Engineering at Xi’an Jiaotong University (2007–2009), establishing a solid foundation for his later work in biomedical and fluidic engineering.

Professional Experience

Dr. Gao’s professional experience is both diverse and impactful. He currently serves at Wannan Medical College (2024–present), focusing on micro-nano fabrication and translational medicine. Previously, at Nanjing University (2019–2024), he advanced bioanalysis, chemical synthesis, and gene editing using microfluidics. His tenure at the Chinese Academy of Sciences (2018–2019) involved developing micro flexible sensors, while earlier roles in France included designing microfluidic oscillators and separating microorganisms using inertial microfluidics. Each position has reinforced his expertise in interdisciplinary applications, from biomedical engineering to fluid mechanics, showcasing his ability to tackle complex challenges across industries.

Research Interests

Dr. Gao’s research interests center on cutting-edge applications of microfluidics and biomedical engineering. He is passionate about inertial microfluidics for particle manipulation, leveraging its potential for analytical and biomedical innovations. His work on nanocatalysis-integrated microfluidic chips aims to advance bioanalysis and molecular diagnostics. Additionally, he explores the CRISPR-Cas system to develop revolutionary point-of-care diagnostic tools. His expertise in micro-electro-mechanical systems (MEMS) fabrication underpins his efforts to bridge fundamental research and practical applications, demonstrating his commitment to advancing interdisciplinary science.

Research Skills

Dr. Gao possesses a versatile skill set that combines technical proficiency with computational expertise. He is experienced in programming languages like MATLAB and R, with familiarity in C++ and Fortran. His software expertise includes engineering tools such as Pro/ENGINEER, CATIA, SolidWorks, and AutoCAD, as well as data analysis tools like ggplot2 and Origin. Proficient in micro-nano fabrication and optical microscopy, he excels in translating complex research into innovative applications. His language fluency in Mandarin, English, and French facilitates international collaborations, enhancing his global research impact.

Awards and Honors

Dr. Gao’s excellence has been recognized through several prestigious awards. He was named a Double-Innovation Doctor of Jiangsu Province (2019) for his innovative research contributions. During his Ph.D. studies, he received the China Scholarship Council Fellowship (2013–2017), supporting his advanced research in France. Earlier in his academic career, he was awarded the Outstanding Student honor and the Siyuan Scholarship at Xi’an Jiaotong University (2008), reflecting his early dedication to academic and research excellence. These accolades underscore his exceptional abilities and commitment to advancing scientific knowledge.

Conclusion

Yanfeng Gao is a highly qualified researcher with a robust background in interdisciplinary science, especially microfluidics and biomedical engineering. His extensive academic and professional experience, technical expertise, and recognition through awards make him a strong candidate for the Best Researcher Award. However, including more detailed metrics of research impact and evidence of leadership roles could strengthen his application. If these areas are addressed, he would undoubtedly stand out as an exceptional contender for the award.

Publication Top Notes

  • Hypoxia‐responsive gene editing to reduce tumor thermal tolerance for mild‐photothermal therapy
    Authors: X. Li, Y. Pan, C. Chen, Y. Gao, X. Liu, K. Yang, X. Luan, D. Zhou, F. Zeng, …
    Journal: Angewandte Chemie 133 (39), 21370-21374
    Year: 2021
    Citations: 113
  • Migration of finite sized particles in a laminar square channel flow from low to high Reynolds numbers
    Authors: M. Abbas, P. Magaud, Y. Gao, S. Geoffroy
    Journal: Physics of Fluids 26 (12)
    Year: 2014
    Citations: 98
  • Gallium–Carbenicillin Framework Coated Defect‐Rich Hollow TiO2 as a Photocatalyzed Oxidative Stress Amplifier against Complex Infections
    Authors: J. Yang, C. Wang, X. Liu, Y. Yin, Y.H. Ma, Y. Gao, Y. Wang, Z. Lu, Y. Song
    Journal: Advanced Functional Materials 30 (43), 2004861
    Year: 2020
    Citations: 69
  • Gold nanoparticles doped metal-organic frameworks as near-infrared light-enhanced cascade nanozyme against hypoxic tumors
    Authors: X. Liu, Y. Pan, J. Yang, Y. Gao, T. Huang, X. Luan, Y. Wang, Y. Song
    Journal: Nano Research 13, 653-660
    Year: 2020
    Citations: 66
  • Nano-immunosorbent assay based on Cas12a/crRNA for ultra-sensitive protein detection
    Authors: Q. Zhao, Y. Pan, X. Luan, Y. Gao, X. Zhao, Y. Liu, Y. Wang, Y. Song
    Journal: Biosensors and Bioelectronics 190, 113450
    Year: 2021
    Citations: 55
  • Self-ordered particle trains in inertial microchannel flows
    Authors: Y. Gao, P. Magaud, L. Baldas, C. Lafforgue, M. Abbas, S. Colin
    Journal: Microfluidics and Nanofluidics 21, 1-10
    Year: 2017
    Citations: 55
  • Emerging trends in organ-on-a-chip systems for drug screening
    Authors: Y. Wang, Y. Gao, Y. Pan, D. Zhou, Y. Liu, Y. Yin, J. Yang, Y. Wang, Y. Song
    Journal: Acta Pharmaceutica Sinica B 13 (6), 2483-2509
    Year: 2023
    Citations: 41
  • Mesopore to macropore transformation of metal–organic framework for drug delivery in inflammatory bowel disease
    Authors: Y. Yin, J. Yang, Y. Pan, Y. Gao, L. Huang, X. Luan, Z. Lin, W. Zhu, Y. Li, Y. Song
    Journal: Advanced Healthcare Materials 10 (3), 2000973
    Year: 2021
    Citations: 38
  • Hollow covalent organic framework-sheltering CRISPR/Cas12a as an in-vivo nanosensor for ATP imaging
    Authors: Y. Pan, X. Luan, F. Zeng, Q. Xu, Z. Li, Y. Gao, X. Liu, X. Li, X. Han, J. Shen, …
    Journal: Biosensors and Bioelectronics 209, 114239
    Year: 2022
    Citations: 37
  • Inertial lateral migration and self-assembly of particles in bidisperse suspensions in microchannel flows
    Authors: Y. Gao, P. Magaud, C. Lafforgue, S. Colin, L. Baldas
    Journal: Microfluidics and Nanofluidics 23, 1-14
    Year: 2019
    Citations: 35

 

 

Pi-Wan Cheng | Molecular Biology | Best Researcher Award

Prof. Dr. Pi-Wan Cheng | Molecular Biology | Best Researcher Award

Professor at University of Nebraska Medical Center, United States

Dr. Pi Wan Cheng is a distinguished biochemist and molecular biologist with over four decades of experience in research and academia. He currently holds a professorship at the University of Nebraska Medical Center (UNMC) and has contributed significantly to the field of glycobiology. Dr. Cheng has made pivotal advancements in understanding glycan biosynthesis and its role in health, diseases, and cancer. His work, which bridges basic and translational research, is supported by multiple research grants and patents. He has also been an active member of several professional organizations, underscoring his influence in the scientific community. Dr. Cheng’s research focuses on how glycosylation affects immune responses and cancer progression, with a special emphasis on the development of Siglec-7-based therapies for pancreatic cancer.

Professional Profile

Education:

Dr. Pi Wan Cheng obtained his Ph.D. in Biochemistry from Case Western Reserve University, Cleveland, Ohio, in 1975. Prior to that, he earned his M.S. in Biochemistry from National Taiwan University in 1968, following his B.S. in Agricultural Chemistry from the same institution in 1965. Throughout his educational journey, Dr. Cheng worked under the mentorship of prominent scientists such as Dr. Don M. Carlson and Dr. Kuo Huang Ling, which shaped his academic and professional growth in biochemistry and molecular biology.

Professional Experience:

Dr. Cheng’s career spans numerous prestigious academic institutions. He has held faculty positions at Case Western Reserve University, the University of North Carolina, and UNMC. At UNMC, he has been a professor in the Department of Biochemistry and Molecular Biology since 1995, where he was granted tenure in 1997. He also served as a research chemist at the Veterans Affairs Nebraska Western Iowa Health Care System from 2011 to 2017. His role at UNMC also includes courtesy appointments in the College of Pharmacy and the Eppley Institute for Cancer Research, where he has fostered collaborations and contributed to the institution’s research landscape.

Research Interest:

Dr. Cheng’s primary research interest lies in glycobiology, specifically the mechanisms of glycan biosynthesis and its impact on health and disease. His work focuses on understanding how glycans, particularly sialylated O-glycans, influence immune responses and contribute to the progression of diseases such as cancer. He investigates how specific glycans, induced by factors like interleukin-6 and alcohol, can protect cancer cells from immune surveillance and promote tumor growth. His innovative research is also exploring therapies targeting Siglec-7 for pancreatic cancer treatment, with potential applications in immunotherapy and cancer prevention.

Research Skills:

Dr. Cheng possesses a comprehensive skill set in biochemistry, molecular biology, and glycobiology. He is skilled in techniques related to protein biochemistry, glycan analysis, immunology, and cancer research. His expertise includes the development of molecular models to understand glycan interactions with immune cells, as well as employing various biochemical assays to assess glycan expression in disease states. Dr. Cheng’s proficiency extends to experimental design, grant writing, and leading interdisciplinary research teams. He has also contributed to the field through patents, underscoring his ability to translate fundamental discoveries into real-world applications.

Awards and Honors:

Throughout his career, Dr. Cheng has received numerous accolades for his groundbreaking research in glycobiology. His work has been supported by prestigious grants, including those from the Nebraska Department of Health and Human Services, where he has led multiple research projects related to cancer and immune function. He holds patents in biologically active molecule delivery, reflecting his innovative contributions to science. Dr. Cheng is a lifetime member of the Society for Glycobiology and the Society of Chinese Bioscientists in America, and he has been recognized for his service to the scientific community through various professional society memberships and community volunteer work.

Conclusion:

Dr. Pi Wan Cheng is a highly qualified candidate for the Best Researcher Award, with a distinguished career marked by significant research contributions in glycobiology, a track record of continuous funding, and active involvement in the scientific community. His innovative research, particularly in cancer immunology and glycosylation, holds great promise for medical advancements. While there is room for further interdisciplinary collaboration and publication visibility, his foundational work in glycobiology makes him a deserving nominee for this prestigious award.

Publication Top Notes

  1. Markers of malignant prostate cancer cells: Golgi localization of α-mannosidase 1A at GM130-GRASP65 site and appearance of high mannose N-glycans on cell surface
    • Authors: Cheng, P.-W., Davidson, S., Bhat, G.
    • Year: 2020
    • Citations: 12
  2. Inhibitory activity of salivary glycoproteins on phytohemagglutins (PHA): Possible molecules to enhance nutritional quality of red kidney beans
    • Authors: Chachadi, V.B., Nayanegali, T.R., Pujari, B.G., Inamdar, S.R., Cheng, P.-W.
    • Year: 2020
    • Citations: 3
  3. p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance
    • Authors: Miller, D.R., Ingersoll, M.A., Chatterjee, A., Oberley-Deegan, R.E., Lin, M.-F.
    • Year: 2019
    • Citations: 18
  4. Shifted Golgi targeting of glycosyltransferases and α-mannosidase IA from giantin to GM130-GRASP65 results in formation of high mannose N-glycans in aggressive prostate cancer cells
    • Authors: Bhat, G., Hothpet, V.-R., Lin, M.-F., Cheng, P.-W.
    • Year: 2017
    • Citations: 18
  5. The role of Rab6a and phosphorylation of non-muscle myosin IIA tailpiece in alcohol-induced Golgi disorganization
    • Authors: Petrosyan, A., Casey, C.A., Cheng, P.-W.
    • Year: 2016
    • Citations: 22
  6. Downregulation of the small GTPase SAR1A: A key event underlying alcohol-induced Golgi fragmentation in hepatocytes
    • Authors: Petrosyan, A., Cheng, P.-W., Clemens, D.L., Casey, C.A.
    • Year: 2015
    • Citations: 20
  7. Glycosyltransferases involved in the synthesis of MUC-associated metastasis-promoting selectin ligands
    • Authors: Chachadi, V.B., Bhat, G., Cheng, P.-W.
    • Year: 2015
    • Citations: 15
  8. Keratin 1 plays a critical role in Golgi localization of core 2 N-acetylglucosaminyltransferase M via interaction with its cytoplasmic tail
    • Authors: Petrosyan, A., Ali, M.F., Cheng, P.-W.
    • Year: 2015
    • Citations: 20
  9. Restoration of compact Golgi morphology in advanced prostate cancer enhances susceptibility to galectin-1-induced apoptosis by modifying mucin O-glycan synthesis
    • Authors: Petrosyan, A., Holzapfel, M.S., Muirhead, D.E., Cheng, P.-W.
    • Year: 2014
    • Citations: 64
  10. Golgi fragmentation induced by heat shock or inhibition of heat shock proteins is mediated by non-muscle myosin IIA via its interaction with glycosyltransferases
    • Authors: Petrosyan, A., Cheng, P.-W.
    • Year: 2014
    • Citations: 24

 

Xiumin Wang | Molecular Biology | Women Researcher Award

Prof. Dr. Xiumin Wang | Molecular Biology | Women Researcher Award

Researcher at Feed Research Institute, Chinese Academy of Agricultural Sciences, China

Dr. Wang Xiumin is a distinguished researcher currently serving at the Institute of Feed Research, Chinese Academy of Agricultural Sciences (CAAS). With a profound academic background and extensive research experience in the field of plant pathology and microbial resistance, Dr. Wang has become a leading figure in her field. Over her career, she has focused on microbial resistance, antibacterial peptides, and the development of therapeutic strategies to combat infectious diseases, especially those involving multi-drug resistant pathogens. Dr. Wang’s work has been instrumental in bridging the gap between fundamental microbiology and applied agricultural practices, contributing to the development of feed-related solutions and sustainable agricultural practices. Her research is widely recognized through numerous publications in prestigious scientific journals, where she has co-authored over 80 papers.

Professional Profile

Education:

Dr. Wang Xiumin obtained her Ph.D. in Plant Pathology from Northwest Agriculture & Forestry University in 2006, after completing her Master’s and Bachelor’s degrees at the same institution in 2003 and 2000, respectively. Her academic training equipped her with in-depth knowledge in plant protection and pathology, laying a strong foundation for her career in agricultural sciences and microbiology. Her academic journey enabled her to focus on plant diseases, microbiology, and biotechnology, advancing her research in combating bacterial resistance in agricultural systems.

Professional Experience:

Dr. Wang Xiumin has accumulated extensive professional experience across various prestigious institutions. From 2006 to 2009, she worked as a Postdoctoral Fellow at Beijing Forestry University, engaging in critical research in plant pathology. Between 2009 and 2013, she served as an Assistant Researcher at the Feed Research Institute of CAAS. Since 2013, she has held the position of Associate Researcher at the same institute. In 2019-2020, she visited the School of Chemistry and Molecular Biosciences at the University of Queensland, further enhancing her expertise in molecular biosciences and plant pathology. Throughout her career, Dr. Wang has continually advanced her research while mentoring emerging scientists in her field.

Research Interests:

Dr. Wang’s research interests lie at the intersection of microbial resistance, plant pathology, and feed-related research. Her work primarily focuses on antibacterial peptides, microbial resistance mechanisms, and the development of therapeutic proteins and peptides. She has also contributed to studies on food safety, including the detoxification of mycotoxins, and has explored the therapeutic potential of marine peptides for bacterial infections. Dr. Wang’s research in microbial resistance and peptide-based therapeutics is crucial for advancing sustainable agricultural and clinical practices, particularly in the context of combating drug-resistant pathogens in both animals and humans.

Research Skills:

Dr. Wang Xiumin is highly skilled in a variety of research techniques including molecular biology, microbiology, and biotechnology. She has experience in the design and application of antibacterial peptides, the isolation and characterization of bioactive compounds, and the assessment of microbial resistance mechanisms. Her expertise also extends to advanced techniques in molecular cloning, protein expression, and peptide synthesis. Additionally, Dr. Wang is adept at using in vitro and in vivo models to study the effects of therapeutic peptides and other compounds on microbial infections. Her diverse skill set has been pivotal in advancing her research projects and making significant contributions to agricultural and health sciences.

Awards and Honors:

Dr. Wang Xiumin has received several accolades for her outstanding contributions to the field of plant pathology and microbiology. She has been recognized for her innovative research in microbial resistance and peptide-based therapeutics, receiving awards from various scientific and agricultural bodies in China. Her significant publications in high-impact journals such as Science of the Total Environment, Journal of Medicinal Chemistry, and Food Chemistry have cemented her reputation as a leading researcher in her field. Additionally, her collaborative work with international research institutes has earned her several fellowships, including her research visit to the University of Queensland, further acknowledging her impact on global agricultural science and medical microbiology.

Conclusion

Dr. Wang Xiumin demonstrates a strong and well-rounded research profile, with impressive publications and a proven ability to address complex issues in plant pathology and antimicrobial resistance. His work is highly relevant and impactful in agricultural and biomedical fields. His contributions place him as a strong candidate for the Excellence in Research Award. Expanding his industry collaborations and mentoring roles would elevate his profile further, making him an even more influential figure in his field.

Publication Top Notes

  1. Application of Lactobacillus plantarum and Pediococcus lactis on Lipid Metabolism, Anti-Inflammatory, and Fecal Microbiota in Cats
    • Authors: Shukun Liang, Xinshu Gu, Jintao Sun, Xiumin Wang, Hui Tao, Zhenlong Wang, Yougang Zhong, Jinquan Wang, Bing Han
    • Year: 2024
    • DOI: 10.3390/microorganisms12122446
  2. Application of Network Pharmacology, Molecular Docking, and In Vitro Experimental Evaluation to Decipher the Anti-Inflammatory Mechanisms of Cirsium japonicum
    • Authors: Jiaxue Wang, Hui Tao, Zhenlong Wang, Wei An, Ya Zhao, Bing Han, Jinquan Wang, Xiuzhu Sun, Xiumin Wang
    • Year: 2024
    • DOI: 10.3390/app14219687
  3. Simultaneous Degradation of AFB1 and ZEN by CotA Laccase from Bacillus subtilis ZJ-2019-1 in the Mediator-Assisted or Immobilization System
    • Authors: Boquan Gao, Wei An, Jianwen Wu, Xiumin Wang, Bing Han, Hui Tao, Jie Liu, Zhenlong Wang, Jinquan Wang
    • Year: 2024
    • DOI: 10.3390/toxins16100445
  4. Allergies to Allergens from Cats and Dogs: A Review and Update on Sources, Pathogenesis, and Strategies
    • Authors: Wei An, Ting Li, Xinya Tian, Xiaoxin Fu, Chunxiao Li, Zhenlong Wang, Jinquan Wang, Xiumin Wang
    • Year: 2024
    • DOI: 10.3390/ijms251910520
  5. Bacillus subtilis Simultaneously Detoxified Aflatoxin B1 and Zearalenone
    • Authors: Jianwen Wu, Zhenlong Wang, Wei An, Boquan Gao, Chunxiao Li, Bing Han, Hui Tao, Jinquan Wang, Xiumin Wang, Huanrong Li
    • Year: 2024
    • DOI: 10.3390/app14041589
  6. The Effect of Lactobacillus plantarum on the Fecal Microbiota, Short Chain Fatty Acids, Odorous Substances, and Blood Biochemical Indices of Cats
    • Authors: Bing Han, Shukun Liang, Jintao Sun, Hui Tao, Zhenlong Wang, Baosheng Liu, Xiumin Wang, Jie Liu, Jinquan Wang
    • Year: 2024
    • DOI: 10.3390/microorganisms12010091
  7. Comparison Study of Two Fumonisin-Degrading Enzymes for Detoxification in Piglets
    • Authors: Zhenlong Wang, Zonghao Lv, Tibor Czabany, Veronika Nagl, Rudolf Krska, Xiumin Wang, Bing Han, Hui Tao, Jie Liu, Jinquan Wang
    • Year: 2023
    • DOI: 10.3390/toxins16010003
  8. The Effect of Duck Bile Acid Extract on the Fecal Microbiota, Short Chain Fatty Acids, Fat Digestibility and Blood Biochemical Indices in Cats
    • Authors: Bing Han, Peng Zhao, Shukun Liang, Zhenlong Wang, Hui Tao, Xiumin Wang, Jie Liu, Jinquan Wang
    • Year: 2023
    • DOI: 10.3390/app13179713
  9. A Screening Model of Antibacterial Agents Based on Escherichia coli Cell-Division Protein
    • Authors: Qiuyu Fan, Jianwen Wu, Bolin Xi, Chunxiao Li, Xiumin Wang, Huanrong Li
    • Year: 2023
    • DOI: 10.3390/app13074493
  10. Mini-Review: Antibiotic-Resistant Escherichia coli from Farm Animal-Associated Sources
    • Authors: ChunMing Xu, Lingqiang Kong, Yonghong Liao, Yuan Tian, Qi Wu, Haosi Liu, Xiumin Wang
    • Year: 2022
    • DOI: 10.3390/antibiotics11111535

 

Sukhes Mukherjee | Molecular Biology | Outstanding Scientist Award

Dr. Sukhes Mukherjee | Molecular Biology | Outstanding Scientist Award

Additional Professor at All India Institute Of Medical Sciences Bhopal, India

Dr. Sukhes Mukherjee is a distinguished academic and researcher in the field of biochemistry, with a focus on clinical biochemistry and molecular biology. He currently holds the position of Additional Professor at the All India Institute of Medical Sciences (AIIMS), Bhopal, India. Dr. Mukherjee has built an impressive career over the past 16 years, with substantial contributions to research and education. His work has been widely recognized, earning him numerous awards and honors. He is also known for his leadership in teaching and mentoring students, particularly at the postgraduate level. Dr. Mukherjee’s research focuses on advancing molecular techniques in biochemistry, with an emphasis on health diagnostics and disease management. He has authored over 80 peer-reviewed papers and frequently contributes to conferences and seminars both nationally and internationally.

Professional Profile

Education

Dr. Mukherjee’s educational journey is anchored in biochemistry and molecular biology. He completed his undergraduate and postgraduate education in India, earning a Master’s degree in Medical Biochemistry, followed by a Ph.D. in Biochemistry. His academic training has provided him with a strong foundation in both theoretical knowledge and hands-on laboratory skills. Dr. Mukherjee’s education is complemented by postdoctoral research experiences that have enriched his expertise in clinical biochemistry and molecular diagnostics. He has actively engaged in interdisciplinary training programs and research initiatives, which have shaped his current position as a thought leader in the field.

Professional Experience

Dr. Mukherjee’s professional experience spans more than 16 years, during which he has worked at various prestigious institutions, most notably at AIIMS, Bhopal. In his current role, he is responsible for overseeing clinical biochemistry research, teaching, and administration. Dr. Mukherjee has taught a wide range of courses, from basic biochemistry to advanced molecular biology, guiding both undergraduate and postgraduate students. Additionally, he has served on various academic and research committees, contributing to the development of new curricula and research protocols. His career also includes serving as a mentor to numerous graduate students and postdoctoral researchers, helping them advance their scientific careers.

Research Interests

Dr. Mukherjee’s primary research interests lie in the fields of clinical biochemistry, molecular biology, and health diagnostics. His work focuses on understanding the molecular mechanisms of disease, with particular attention to neurochemistry and biochemical pathways in neurological disorders. He is involved in exploring novel diagnostic biomarkers and therapies to improve patient care. Dr. Mukherjee’s research also covers the application of cutting-edge molecular biology techniques to better understand human health and disease at the cellular and biochemical levels. His interdisciplinary approach includes collaborations with clinicians and other researchers to bridge the gap between benchside research and clinical applications.

Research Skills

Dr. Mukherjee is highly skilled in a range of laboratory techniques and methodologies that are integral to biochemistry and molecular biology. These include protein chemistry, molecular cloning, enzyme assays, and biochemical profiling. He is proficient in various advanced diagnostic techniques, such as mass spectrometry and PCR-based methods, that are essential in clinical research. Dr. Mukherjee also has extensive experience in bioinformatics and data analysis, utilizing computational tools to interpret complex biological data. His research skills are complemented by his ability to manage large-scale research projects and collaborate effectively with multidisciplinary teams.

Awards and Honors

Dr. Mukherjee’s contributions to biochemistry and molecular biology have been recognized through numerous awards and honors. Notably, he received the Best Paper Award from the Association of Clinical Biochemists of India in 2008. He has been a recipient of various travel fellowships to attend and present at international conferences, including those in the US and South Korea. Dr. Mukherjee is a Fellow of the Linnean Society of London, reflecting his international stature in the scientific community. His work continues to attract recognition, both in India and globally, for its impact on advancing clinical biochemistry and molecular diagnostics.

Conclusion

Dr. Sukhes Mukherjee is undoubtedly a highly deserving candidate for the Best Researcher Award, with an impressive record of research contributions, academic excellence, and professional recognition. His extensive research, leadership, and dedication to advancing the field of clinical biochemistry set him apart as a pioneer in his field. With a bit more focus on interdisciplinary research and mentorship, Dr. Mukherjee could have an even more profound influence on both the scientific community and society at large. This nomination reflects his exemplary contributions and positions him as a role model for future researchers in the field.

Publication Top Notes

  1. Alcoholism and its effects on the central nervous system
    Authors: S Mukherjee
    Journal: Current Neurovascular Research 10 (3), 256-262
    Year: 2013
    Citations: 138
  2. Consequences of alcohol consumption on neurotransmitters-an overview
    Authors: S Mukherjee, SK Das, K Vaidyanathan, DM Vasudevan
    Journal: Current Neurovascular Research 5 (4), 266-272
    Year: 2008
    Citations: 86
  3. Evaluation of blood oxidative stress‐related parameters in alcoholic liver disease and non‐alcoholic fatty liver disease
    Authors: SK Das, V Balakrishnan, S Mukherjee, DM Vasudevan
    Journal: Scandinavian Journal of Clinical and Laboratory Investigation 68 (4), 323-334
    Year: 2008
    Citations: 81
  4. Oxidative stress is the primary event: effects of ethanol consumption in brain
    Authors: SK Das, KR Hiran, S Mukherjee, DM Vasudevan
    Journal: Indian Journal of Clinical Biochemistry 22, 99-104
    Year: 2007
    Citations: 77
  5. Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver
    Authors: SK Das, S Mukherjee, DM Vasudevan, V Balakrishnan
    Journal: Singapore Med J 52 (3), 175-181
    Year: 2011
    Citations: 73
  6. Medicinal properties of milk thistle with special reference to silymarin–an overview
    Authors: SK Das, S Mukherjee, DM Vasudevan
    Publisher: CSIR
    Year: 2008
    Citations: 70
  7. Evolving interplay between dietary polyphenols and gut microbiota—an emerging importance in healthcare
    Authors: SK Ray, S Mukherjee
    Journal: Frontiers in Nutrition 8, 634944
    Year: 2021
    Citations: 68
  8. Biochemical and immunological basis of silymarin effect, a milk thistle (Silybum marianum) against ethanol-induced oxidative damage
    Authors: SK Das, S Mukherjee
    Journal: Toxicology Mechanisms and Methods 22 (5), 409-413
    Year: 2012
    Citations: 63
  9. Protective effect of resveratrol and vitamin E against ethanol-induced oxidative damage in mice: biochemical and immunological basis
    Authors: SK Das, S Mukherjee, G Gupta, DN Rao, DM Vasudevan
    Publisher: CSIR
    Year: 2010
    Citations: 55
  10. Effects of chronic ethanol exposure on renal function tests and oxidative stress in kidney
    Authors: SK Das, S Varadhan, L Dhanya, S Mukherjee, DM Vasudevan
    Journal: Indian Journal of Clinical Biochemistry 23, 341-344
    Year: 2008
    Citations: 49